A multicenter, retrospective study of Blinatumomab of children and young adults with relapsed or refractory B-cell acute lymphoblastic leukemia
Latest Information Update: 20 Nov 2021
At a glance
- Drugs Blinatumomab (Primary)
- Indications Precursor B-cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 20 Nov 2021 New trial record
- 12 Nov 2021 Results published in the Journal of Clinical Oncology